RhumbLine Advisers’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $735K | Buy |
|
|||||
|
2025
Q2 | $271K | Buy |
|
|||||
|
2025
Q1 | $340K | Sell |
|
|||||
|
2024
Q4 | $543K | Buy |
|
|||||
|
2024
Q3 | $401K | Sell |
|
|||||
|
2024
Q2 | $560K | Buy |
|
|||||
|
2024
Q1 | $10.1K | Hold |
|
|||||
|
2023
Q4 | $11.3K | Hold |
|
|||||
|
2023
Q3 | $3.71K | Sell |
|
|||||
|
2023
Q2 | $9.92K | Sell |
|
|||||
|
2023
Q1 | $158K | Buy |
|
|||||
|
2022
Q4 | $578K | Buy |
|
|||||
|
2022
Q3 | $574K | Buy |
|
|||||
|
2022
Q2 | $482K | Buy |
|
|||||
|
2022
Q1 | $249K | Buy |
|
|||||
|
2021
Q4 | $156K | Sell |
|
|||||
|
2021
Q3 | $381K | Sell |
|
|||||
|
2021
Q2 | $695K | Buy |
|
|||||
|
2021
Q1 | $900K | Sell |
|
|||||
|
2020
Q4 | $909K | Buy |
|
|||||
|
2020
Q3 | $1.26M | Sell |
|
|||||
|
2020
Q2 | $2.24M | Buy |
|
|||||
|
2020
Q1 | $1.2M | Sell |
|
|||||
|
2019
Q4 | $2.32M | Buy |
|
|||||
|
2019
Q3 | $1.32M | Buy |
|
|||||
|
2019
Q2 | $1.67M | Buy |
|
|||||
|
2019
Q1 | $1.25M | Sell |
|
|||||
|
2018
Q4 | $1.45M | Buy |
|
|||||
|
2018
Q3 | $965K | Sell |
|
|||||
|
2018
Q2 | $904K | Buy |
|
|||||
|
2018
Q1 | $1.24M | Sell |
|
|||||
|
2017
Q4 | $1.18M | Sell |
|
|||||
|
2017
Q3 | $1.03M | Buy |
|
|||||
|
2017
Q2 | $858K | Sell |
|
|||||
|
2017
Q1 | $677K | Buy |
|
|||||
|
2016
Q4 | $205K | Sell |
|
|||||
|
2016
Q3 | $240K | Buy |
|
|||||
|
2016
Q2 | $170K | Buy |
|
|||||
|
2016
Q1 | $229K | Buy |
|
|||||
|
2015
Q4 | $299K | Buy |
|
|||||
|
2015
Q3 | $285K | Buy |
|
|||||
|
2015
Q2 | $939K | Buy |
|
|||||
|
2015
Q1 | $490K | Buy |
|